Safety Study of BMS-823778 in Subjects With Type 2 Diabetes

NCT01111955 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: BMS-823778
DRUG: BMS-823778
DRUG: BMS-823778
DRUG: Placebo
DRUG: Metformin

Sponsor

Bristol-Myers Squibb